A
$ Value
$11K
Shares
14,355
Price
$1
Filed
Jun 27
Insider
Name
Winton Matthew
Title
COO
CIK
0001971400
Roles
Officer
Transaction Details
Transaction Date
2025-06-25
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,743
Footnotes
Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2025 through June 25, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on April 1, 2025, the first trading day of the purchase period.
Filing Info
Winton Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-18 | CRVO | ▲ | $12K |
| 2025-11-17 | CRVO | ▲ | $30K |
| 2025-11-14 | CRVO | ▲ | $76K ★ |
| 2025-10-06 | CRVO | A | $0 |
| 2025-07-01 | INZY | U | $87K |
| 2025-07-01 | INZY | D | — |
| 2025-07-01 | INZY | D | — |
| 2025-06-25 | INZY | A | $11K |
Other Insiders at INZY (90d)
No other insider activity at this issuer in the last 90 days.